Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Biogenesis of lysosome-related organelles complex-1 (BORC) regulates late endosomal/lysosomal size through PIKfyve-dependent phosphatidylinositol-3,5-bisphosphate.

Yordanov TE, Hipolito VEB, Liebscher G, Vogel GF, Stasyk T, Herrmann C, Geley S, Teis D, Botelho RJ, Hess MW, Huber LA.

Traffic. 2019 Sep;20(9):674-696. doi: 10.1111/tra.12679.

2.

Combining high-pressure freezing with pre-embedding immunogold electron microscopy and tomography.

Hess MW, Vogel GF, Yordanov TE, Witting B, Gutleben K, Ebner HL, de Araujo MEG, Filipek PA, Huber LA.

Traffic. 2018 Aug;19(8):639-649. doi: 10.1111/tra.12575. Epub 2018 May 21.

3.

Recruitment dynamics of ESCRT-III and Vps4 to endosomes and implications for reverse membrane budding.

Adell MAY, Migliano SM, Upadhyayula S, Bykov YS, Sprenger S, Pakdel M, Vogel GF, Jih G, Skillern W, Behrouzi R, Babst M, Schmidt O, Hess MW, Briggs JA, Kirchhausen T, Teis D.

Elife. 2017 Oct 11;6. pii: e31652. doi: 10.7554/eLife.31652.

4.

LAMTOR/Ragulator is a negative regulator of Arl8b- and BORC-dependent late endosomal positioning.

Filipek PA, de Araujo MEG, Vogel GF, De Smet CH, Eberharter D, Rebsamen M, Rudashevskaya EL, Kremser L, Yordanov T, Tschaikner P, Fürnrohr BG, Lechner S, Dunzendorfer-Matt T, Scheffzek K, Bennett KL, Superti-Furga G, Lindner HH, Stasyk T, Huber LA.

J Cell Biol. 2017 Dec 4;216(12):4199-4215. doi: 10.1083/jcb.201703061. Epub 2017 Oct 9.

5.

Disrupted apical exocytosis of cargo vesicles causes enteropathy in FHL5 patients with Munc18-2 mutations.

Vogel GF, van Rijn JM, Krainer IM, Janecke AR, Posovszky C, Cohen M, Searle C, Jantchou P, Escher JC, Patey N, Cutz E, Müller T, Middendorp S, Hess MW, Huber LA.

JCI Insight. 2017 Jul 20;2(14). pii: 94564. doi: 10.1172/jci.insight.94564. eCollection 2017 Jul 20.

6.

Abnormal Rab11-Rab8-vesicles cluster in enterocytes of patients with microvillus inclusion disease.

Vogel GF, Janecke AR, Krainer IM, Gutleben K, Witting B, Mitton SG, Mansour S, Ballauff A, Roland JT, Engevik AC, Cutz E, Müller T, Goldenring JR, Huber LA, Hess MW.

Traffic. 2017 Jul;18(7):453-464. doi: 10.1111/tra.12486. Epub 2017 May 17.

7.

Towards understanding microvillus inclusion disease.

Vogel GF, Hess MW, Pfaller K, Huber LA, Janecke AR, Müller T.

Mol Cell Pediatr. 2016 Dec;3(1):3. doi: 10.1186/s40348-016-0031-0. Epub 2016 Jan 29.

8.

Cargo-selective apical exocytosis in epithelial cells is conducted by Myo5B, Slp4a, Vamp7, and Syntaxin 3.

Vogel GF, Klee KM, Janecke AR, Müller T, Hess MW, Huber LA.

J Cell Biol. 2015 Nov 9;211(3):587-604. doi: 10.1083/jcb.201506112.

9.

An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking.

Schneeberger K, Vogel GF, Teunissen H, van Ommen DD, Begthel H, El Bouazzaoui L, van Vugt AH, Beekman JM, Klumperman J, Müller T, Janecke A, Gerner P, Huber LA, Hess MW, Clevers H, van Es JH, Nieuwenhuis EE, Middendorp S.

Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12408-13. doi: 10.1073/pnas.1516672112. Epub 2015 Sep 21.

10.

Ultrastructural Morphometry Points to a New Role for LAMTOR2 in Regulating the Endo/Lysosomal System.

Vogel GF, Ebner HL, de Araujo ME, Schmiedinger T, Eiter O, Pircher H, Gutleben K, Witting B, Teis D, Huber LA, Hess MW.

Traffic. 2015 Jun;16(6):617-34. doi: 10.1111/tra.12271. Epub 2015 Apr 14.

11.

Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progression.

Csiszar A, Kutay B, Wirth S, Schmidt U, Macho-Maschler S, Schreiber M, Alacakaptan M, Vogel GF, Aumayr K, Huber LA, Beug H.

Breast Cancer Res. 2014 Sep 9;16(5):433. doi: 10.1186/s13058-014-0433-7.

12.

Loss of syntaxin 3 causes variant microvillus inclusion disease.

Wiegerinck CL, Janecke AR, Schneeberger K, Vogel GF, van Haaften-Visser DY, Escher JC, Adam R, Thöni CE, Pfaller K, Jordan AJ, Weis CA, Nijman IJ, Monroe GR, van Hasselt PM, Cutz E, Klumperman J, Clevers H, Nieuwenhuis EE, Houwen RH, van Haaften G, Hess MW, Huber LA, Stapelbroek JM, Müller T, Middendorp S.

Gastroenterology. 2014 Jul;147(1):65-68.e10. doi: 10.1053/j.gastro.2014.04.002. Epub 2014 Apr 12.

PMID:
24726755
13.

Coordinated binding of Vps4 to ESCRT-III drives membrane neck constriction during MVB vesicle formation.

Adell MA, Vogel GF, Pakdel M, Müller M, Lindner H, Hess MW, Teis D.

J Cell Biol. 2014 Apr 14;205(1):33-49. doi: 10.1083/jcb.201310114. Epub 2014 Apr 7.

14.

Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells.

Amann A, Zwierzina M, Gamerith G, Bitsche M, Huber JM, Vogel GF, Blumer M, Koeck S, Pechriggl EJ, Kelm JM, Hilbe W, Zwierzina H.

PLoS One. 2014 Mar 24;9(3):e92511. doi: 10.1371/journal.pone.0092511. eCollection 2014.

15.

Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity.

Thoeni CE, Vogel GF, Tancevski I, Geley S, Lechner S, Pfaller K, Hess MW, Müller T, Janecke AR, Avitzur Y, Muise A, Cutz E, Huber LA.

Traffic. 2014 Jan;15(1):22-42. doi: 10.1111/tra.12131. Epub 2013 Nov 19.

16.

Cryo-immunoelectron microscopy of adherent cells improved by the use of electrospun cell culture substrates.

Schmiedinger T, Vogel GF, Eiter O, Pfaller K, Kaufmann WA, Flörl A, Gutleben K, Schönherr S, Witting B, Lechleitner TW, Ebner HL, Seppi T, Hess MW.

Traffic. 2013 Aug;14(8):886-94. doi: 10.1111/tra.12080. Epub 2013 May 23.

17.

FlgM as a secretion moiety for the development of an inducible type III secretion system.

Heel T, Vogel GF, Lammirato A, Schneider R, Auer B.

PLoS One. 2013;8(3):e59034. doi: 10.1371/journal.pone.0059034. Epub 2013 Mar 12.

Supplemental Content

Loading ...
Support Center